Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to page options Skip directly to site content

ACIP logoThe Advisory Committee on Immunization Practices (ACIP) is a group of medical and public health experts that develop recommendations on use of vaccines in the civilian population of the United States...

More

laptop

Register for upcoming October ACIP meeting

October 19-20, 2016

Deadline for registration:
Non-US Citizens: September 28, 2016
US Citizens: October 10, 2016

Registration is NOT required to watch the live meeting webcast or to listen via telephone.

Public Comment Instructions [1 page]

ACIP Recommendations

General Committee-related Information

  • Charter
    Defines ACIP's purpose, authority, and function; its structure, meetings, and compensation; plus costs, reports, and termination.
  • Members
    Membership roster, including chair, executive secretary, voting members, ex officio members, and liaison representatives.
  • Articles
    Journal articles about the ACIP.

Guidance

ACIP Flyer

ACIP brochure This ACIP flyer [2 pages] answers questions such as what does the ACIP consider in the vaccine recommendation process, including recommended ages for administration of various vaccines to children?

What's New

ACIP Votes, June 2016

  • ACIP approved the following three recommendations by majority vote on June 22, 2016:
    • Cholera vaccine (CVD 103-HgR, Vaxchora™) is recommended for adult (18-64 years old) travelers to an area of active cholera transmission.
    • Influenza vaccine: In light of concern regarding poor effectiveness against influenza A(H1N1)pdm09 in the U.S. during the 2013-14 and 2015-16 seasons, for the 2016-17 season, ACIP makes the interim recommendation that live attenuated influenza vaccine (LAIV4) should not be used.
    • Meningococcal vaccine: Persons aged ≥2 years with HIV infection who have not been previously vaccinated should receive a 2-dose primary series of MenACWY (0, 2 months). Children 2 months through ≤2 years with HIV infection should receive an age appropriate series of MenACWY.
  • If approved by the CDC Director, the recommendations will become official once published in MMWR.

ACIP Meetings

Top